ArticleAdvances in therapy2025

An Indirect Treatment Comparison of Avalglucosidase Alfa versus Cipaglucosidase Alfa Plus Miglustat in Patients with Late-Onset Pompe Disease.

Mark E Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.